Abstract
Purpose
The aim of this study was to investigate the prognostic significance of the response of primary rectal lesions to preoperative radiotherapy, pathological nodal status, and carcinoembryonic antigen (CEA) levels before and after radiotherapy in rectal cancer patients treated with a total mesorectal excision.
Methods
We investigated the prognostic significance of the clinical and pathological factors in 97 patients treated with preoperative radiotherapy (50–50.4 Gy over 5–6 weeks) followed by curative resections.
Results
A high CEA level (>5 ng/mL) after radiotherapy (hazard ratio, 2.849; 95% confidence interval, 1.061–7.651; p = 0.0377) and pathological lymph node metastasis (hazard ratio, 0.350; 95% confidence interval, 0.154–0.797; p = 0.0124) were independently associated with postoperative recurrence. Although the CEA level before radiotherapy was associated with disease-free survival in a univariate analysis, it lost its statistical significance in a multivariate analysis. The response of the primary rectal lesions, evaluated pathologically by T stage and the degree of regression, was not associated with disease-free survival. In patients without lymph node metastasis, the 5-year disease-free survival of those with a high CEA level after radiotherapy was significantly worse than those with low CEA after radiotherapy (61.6% vs. 89.0%, respectively, p = 0.0234).
Conclusions
Pathological lymph node metastasis and a high CEA level after radiotherapy were independent predictors of a poor outcome in rectal cancer patients treated with preoperative radiotherapy. The CEA level after radiotherapy was capable of discriminating patients with a high risk of recurrence among pathologically node-negative patients.
Similar content being viewed by others
References
Stockholm Rectal Cancer Study Group (1990) Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 66:49–55
Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987
Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 358:1291–1304
Gerard A, Buyse M, Nordlinger B et al (1988) Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 208:606–614
Kapiteijn E, Kranenbarg EK, Steup WH et al (1999) Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch colorectal cancer group. Eur J Surg 165:410–420
Mendenhall WM, Million RR, Bland KI et al (1985) Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum. Ann Surg 202:215–222
Myerson RJ, Genovesi D, Lockett MA et al (1999) Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment. Int J Radiat Oncol Biol Phys 43:537–543
Nagawa H, Muto T, Sunouchi K et al (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44:1274–1280
Watanabe T, Tsurita G, Muto T et al (2002) Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery 132:27–33
Folkesson J, Birgisson H, Pahlman L et al (2005) Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644–5650
Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482
Kiyomatsu T, Watanabe T, Muto T et al (2007) The 4-portal technique decreases adverse effects in preoperative radiotherapy for advanced rectal cancer: comparison between the 2-portal and the 4-portal techniques. Am J Surg 194:542–548
Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American pathologists consensus statement 1999. Arch Pathol Lab Med 124:979–994
Pucciarelli S, Toppan P, Friso ML et al (2004) Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 47:1798–1807
Suarez J, Vera R, Balen E et al (2008) Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis 10:563–568
Tsujinaka S, Kawamura YJ, Konishi F et al (2008) Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer. Int J Colorectal Dis 23:67–76
Beddy D, Hyland JM, Winter DC et al (2008) A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 15:3471–3477
Bujko K, Michalski W, Kepka L et al (2007) Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: an analysis of outcomes in a randomized trial. Int J Radiat Oncol Biol Phys 67:369–377
Chapet O, Romestaing P, Mornex F et al (2005) Preoperative radiotherapy for rectal adenocarcinoma: which are strong prognostic factors? Int J Radiat Oncol Biol Phys 61:1371–1377
Leibold T, Shia J, Ruo L et al (2008) Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol 26:2106–2111
Swedish Rectal Cancer Trial (1993) Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br J Surg 80:1333–1336. doi:1333
Peng JJ, Cai SJ, Lu HF et al (2007) Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers. World J Gastroenterol 13:3009–3015
Das P, Skibber JM, Rodriguez-Bigas MA et al (2007) Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109:1750–1755
Corman O (1998) Colon and rectal surgery, 4th edn. Lippincott Williams, Philadelphia
Sobin L, Wittekind C (2002) TNM classification of malignant tumours. Springer, New York
Japanese Society for Cancer of the Colon and Rectum (2006) General rules for clinical and pathological studies on cancer of the colon, rectum and anus, 7th edn. Kanehara, Tokyo
Takahashi T, Kato T, Kodaira S et al (1996) Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy. Am J Clin Oncol 19:408–415
Park YA, Lee KY, Kim NK et al (2006) Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol 13:645–650
Kim JY, Kim NK, Sohn SK et al (2009) Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. Ann Surg Oncol 16:2771–2778
Larsen SG, Wiig JN, Dueland S et al (2008) Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer. Eur J Surg Oncol 34:410–417
Perez RO, Sao Juliao GP, Habr-Gama A et al (2009) The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Dis Colon Rectum 52:1137–1143
Park JW, Lim SB, Kim DY et al (2009) Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery. Int J Radiat Oncol Biol Phys 74:810–817
Akasu T, Moriya Y, Ohashi Y et al (2006) Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Jpn J Clin Oncol 36:237–244
Hisashige A, Yoshida S, Kodaira S (2008) Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer. Br J Cancer 99:1232–1238
Fietkau R, Barten M, Klautke G et al (2006) Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum 49:1284–1292
Rodel C, Martus P, Papadoupolos T et al (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23:8688–8696
Wong RK, Tandan V, De Silva S et al (2007) Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev. doi:10.1002/14651858, CD002102
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ishihara, S., Watanabe, T., Kiyomatsu, T. et al. Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer. Int J Colorectal Dis 25, 1417–1425 (2010). https://doi.org/10.1007/s00384-010-1051-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-010-1051-1